Skip to main content
SpringerLink
Log in

Ductal Carcinoma In Situ

  • Chapter
  • First Online:
Clinical Algorithms in General Surgery

  • 156 Accesses

Abstract

The diagnosis and management of ductal carcinoma in situ is constantly evolving. Ductal carcinoma in situ is considered a “preinvasive” cancer of the breast, often considered a nonobligate precursor to invasive disease. It is generally discovered on screening mammography by the presence of calcifications. Key components of the history and physical exam can aid the surgeon in determining important aspects in the care of the patient. Treatment includes surgery, in the form of lumpectomy or mastectomy, radiation therapy (RT), and hormone therapy (HT). Axillary staging is usually not necessary unless invasive disease is found. Genomic testing can aid the clinician in making decisions regarding the need for adjuvant therapy, thereby individualizing care for each patient and avoiding unnecessary morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Silverstein M, Lagios M. Ductal carcinoma in situ. In: Keurer H, editor. Keurer’s breast surgical oncology. New York: The McGraw Hill Companies; 2010. p. 189–207.

    Google Scholar 

  2. Lagios M. Duct carcinoma in situ: a Gordian knot untied. In: Scott-Conner C, Dirbas F, editors. Breast surgical techniques and interdisciplinary management. New York: Springer; 2011. p. 623–31.

    Google Scholar 

  3. Sanders M, Schuyler P, Dupont W, Page D. The natural history of low grade ductal carcinoma in suit of the breast in women treated by biopsy only revealed over 30 years of long term follow-up. Cancer. 2005;103:2481–4.

    Article  Google Scholar 

  4. Rosen P, Senie R, Schottenfeld D, Ashikari R. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg. 1979;1989:377–82.

    Article  Google Scholar 

  5. Holland R, Hendriks J, Verbeek A, et al. Extend, distribution, and mammographic/histological correclations of breast ductal carcinoma in situ. Lancet. 1990;335:519–22.

    Article  CAS  Google Scholar 

  6. Eva SS. Rating the risk factors for breast cancer. Ann Surg. 2003;237(4):474–82.

    Google Scholar 

  7. National Comprehensive Cancer Network. Breast cancer. Genetic/familial high-risk assessment: breast and ovarian. Version 3.2017. https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. Accessed 2/2018.

  8. Holland R, Peterse J, Millis R, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol. 1994;11:167–80.

    CAS  PubMed  Google Scholar 

  9. Silverstein MJ, Poller D, Waisman J, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995;345:1154–7.

    Article  CAS  Google Scholar 

  10. Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol. 2001;28:400–18.

    Article  CAS  Google Scholar 

  11. UK Coordinating Committee on Cancer Research (UKCCR), Ductal Carcinoma in Situ (DCIS) Working Party. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situe of the breast in the UK, Australia, and New Zealand: randomized controlled trial. Lancet. 2003;362:95–102.

    Article  Google Scholar 

  12. Viani GA, Stefano EJ, Alfonso SL, et al. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a metaanalysis of randomized trials. Radiat Oncol. 2007;2:28–39.

    Article  Google Scholar 

  13. Fisher B, Constantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328:1581–6.

    Article  CAS  Google Scholar 

  14. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16:441–52.

    Article  CAS  Google Scholar 

  15. Julien J, Bijker N, Fentiman I, et al. Radiotherapy in breast conserving treatment for ducal carcinoma in situ: first results of EORTC randomized phase III trial 10853. Lancet. 2000;355:528–33.

    Article  CAS  Google Scholar 

  16. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999;353:1993–2000.

    Article  CAS  Google Scholar 

  17. Solin LJ, Gray R, Bahner FL, et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2013;105(10):701–10.

    Article  CAS  Google Scholar 

  18. Rackovich E, Nofech-Mozes S, Henna W, et al. A population-based validation study of the DCIS score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Breast Cancer Res Treat. 2015;152(2):389–98.

    Article  Google Scholar 

  19. Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 2014;21(3):704–16.

    Article  Google Scholar 

  20. Rosenberger LH, Mamtani A, Fuzesi S, et al. Early adoption of the SSO-ASTRO consensus guidelines on margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: initial experience from Memorial Sloan Kettering Cancer Center. Ann Surg Oncol. 2016;23(10):3239–46.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, AMITA Health System, Elk Grove Village, IL, USA

    Anjali R. Thawani

  2. Department of Surgery, University of Iowa, Iowa City, IA, USA

    Lillian M. Erdahl

Authors
  1. Anjali R. Thawani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lillian M. Erdahl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lillian M. Erdahl .

Editor information

Editors and Affiliations

  1. Department of Surgery, Stony Brook Medicine, Stony Brook, NY, USA

    Salvatore Docimo Jr.

  2. Department of Surgery, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

    Eric M. Pauli

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Thawani, A.R., Erdahl, L.M. (2019). Ductal Carcinoma In Situ. In: Docimo Jr., S., Pauli, E. (eds) Clinical Algorithms in General Surgery . Springer, Cham. https://doi.org/10.1007/978-3-319-98497-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-98497-1_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-98496-4

  • Online ISBN: 978-3-319-98497-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation